Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sandra Falagan"'
Autor:
Juan Moreno-Rubio, Santiago Ponce, Rosa Álvarez, María Eugenia Olmedo, Sandra Falagan, Xabier Mielgo, Fátima Navarro, Patricia Cruz, Luis Cabezón-Gutiérrez, Carlos Aguado, Gonzalo Colmenarejo, Marta Muñoz-Fernández de Leglaria, Ana Belén Enguita, María Cebollero, Amparo Benito, Isabel Alemany, Carolina del Castillo, Ricardo Ramos, Ana Ramírez de Molina, Enrique Casado, Maria Sereno
Publikováno v:
Cancer Biology & Medicine, Vol 17, Iss 2, Pp 444-457 (2020)
Objective: Long-term survivors (LS) of non-small cell lung cancer (NSCLC) without driver alterations, displaying an overall survival (OS) of more than 3 years, comprise around 10% of cases in several series treated with chemotherapy. There are classi
Externí odkaz:
https://doaj.org/article/36439633311a4ff2ae4cf60b69f45489
Autor:
Fatima Navarro, Sandra Falagan, Luis Cabezon-Gutierrez, X. Mielgo, Carolina Castillo, Carlos Aguado, Enrique Casado, Gonzalo Colmenarejo, Ana Ramírez de Molina, M. Cebollero, Juan Moreno-Rubio, Ana Belén Enguita, María Sereno, Ricardo Luiz Ramos, Isabel Alemany, Patricia Cruz, Santiago Ponce, Rosa Alvarez, Maria Eugenia Olmedo, Amparo Benito, Marta Muñoz-Fernández de Leglaria
Publikováno v:
Cancer Biology & Medicine, Vol 17, Iss 2, Pp 444-457 (2020)
Cancer Biology & Medicine
Cancer Biology & Medicine
Objective: Long-term survivors (LS) of non-small cell lung cancer (NSCLC) without driver alterations, displaying an overall survival (OS) of more than 3 years, comprise around 10% of cases in several series treated with chemotherapy. There are classi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1db68c1321e5a6e593fa15fe0a4d413
http://www.cancerbiomed.org/index.php/cocr/article/view/1621
http://www.cancerbiomed.org/index.php/cocr/article/view/1621
Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer
Autor:
María Sereno, Oliver Higuera, Patricia Cruz Castellanos, Sandra Falagan, Xabier Mielgo-Rubio, Juan Carlos Trujillo-Reyes, Felipe Couñago
Publikováno v:
World Journal of Clinical Oncology
In recent years, studies have explored different combinations of immunotherapy and chemotherapy. The rationale behind these is the improved survival outcomes of new immunologic therapies used in first-line-treatment of advanced non-small cell lung ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb70cf2b9dbee60972c99de2795dd97d
https://pubmed.ncbi.nlm.nih.gov/35070737
https://pubmed.ncbi.nlm.nih.gov/35070737
Autor:
Silvia Roa, Enrique Casado, Carmen Sandoval, Ramiro López-Menchaca, María Merino, Gerardo Gutiérrez-Gutiérrez, Ana María Jimenez-Gordo, Patricia Martínez-Martin, María Sereno, Sandra Falagan
Publikováno v:
Lung Cancer
Lung Cancer (Amsterdam, Netherlands)
Lung Cancer (Amsterdam, Netherlands)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60e7cccc4854f0d67f4a638377b7a126
Autor:
Cristina Aguayo, Sandra Falagan, María Sereno, María Merino, Ana María Jimenez-Gordo, Enrique Casado, Francisco Zambrana, Cesar Gomez Raposo, Silvia Roa, Inmaculada Toboso del Amo, Juan Moreno-Rubio, Miriam López-Gómez, Ana López-Alfonso
Publikováno v:
Journal of Clinical Oncology. 38:e15012-e15012
e15012 Background: Antinuclear antibodies (ANAs) constitute a spectrum of autoantibodies targeted to nuclear and cytoplasmic components of the cells considered serological markers for different autoimmune disease. However, ANAs are also presented in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b41aab782a071a9e092b961ad34e897
https://doi.org/10.1200/jco.2020.38.15_suppl.e15012
https://doi.org/10.1200/jco.2020.38.15_suppl.e15012
Autor:
Sandra Falagan, A. Lopez Martin, R. Lopez Castro, S. Cerezo Gonzalez, Ricard Cervera, L. Cabezón Gutiérrez, E. Pérez Fernández, Pedro Mateos Cruz, A. Gómez Rueda, Jazmina Núñez, A. Calles Blanco, J.M. Sanchez Torres, M. Sotelo Lezama, A.M. Sánchez Peña, X. Mielgo Rubio, E. Martinez Moreno, M. Antoñanzas, C. Pangua Mendez, I. Gómez-Barreda, B. Jimenez Munarriz
Publikováno v:
Annals of Oncology. 30:v619-v620
Background Derived neutrophils/(leukocytes-neutrophils) ratio (dNLR) and lactate dehydrogenase (LDH) level have been correlated with immune checkpoint inhibitors (ICI) outcomes. A lung immune prognostic index (LIPI) that showed association with ICI o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f503380e1395f65bf05f4cd0ab5f451
https://doi.org/10.1093/annonc/mdz260.031
https://doi.org/10.1093/annonc/mdz260.031
Autor:
María Merino, Gerardo Gutiérrez-Gutiérrez, Juan Moreno-Rubio, Francisco Zambrana, Alexandru Vlagea, Enrique Casado, Sandra Falagan, María Sereno
Publikováno v:
Critical reviews in oncology/hematology. 127
Antinuclear antibodies (ANAs) are a spectrum of autoantibodies targeted to various nuclear and cytoplasmic components of the cells. They are very useful as serological markers for different autoimmune disease, like systemic lupus erythematosus (SLE),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d86b63c76c680771b142cab2be1d7e
https://pubmed.ncbi.nlm.nih.gov/29891110
https://pubmed.ncbi.nlm.nih.gov/29891110
Autor:
Sagrario García Sánchez, Juan Moreno Rubio, César Gómez-Raposo, María Sereno, Francisco Zambrana Tébar, Rebeca Hernández Jusdado, Sandra Falagan, Victor Moreno, Enrique Casado Sáenz
Publikováno v:
Anti-Cancer Drugs. 26:1004-1007
Lung adenocarcinoma includes recurrent activating oncogenic mutations (EGFR, EML4-ALK, ROS1) that have been associated with response to EGFR and ALK inhibitors. Platinum-based chemotherapy is the standard therapy for non-oncodrivers population. Soraf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::423f42b05939857b49dc42c3df91e5c3
https://doi.org/10.1097/cad.0000000000000277
https://doi.org/10.1097/cad.0000000000000277
Autor:
X. Mielgo-Rubio, J. Rubio-Martínez, M.J. Sotelo-Lezama, Carlos López, L.E. Chara, E. Zhan Zhou, I. Gómez-Barreda, A. Velastegui, C. Olier-Garate, R. Lopez Castro, J. Silva-Ruiz, A. Cardeña-Gutiérrez, M. Sereno Moyano, Arnoldo Riquelme, Sandra Falagan, J. Moreno Rubio, Coralia Bueno
Publikováno v:
Journal of Thoracic Oncology. 13:S488-S489
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c938416c38b8e4d7094cd04f096db46c
https://doi.org/10.1016/j.jtho.2018.08.625
https://doi.org/10.1016/j.jtho.2018.08.625
Autor:
A.B. Enguita, C. Del Castillo, Maria Eugenia Olmedo, M. Cebollero, Esther Casado, Sandra Falagan, Isabel Alemany, R. Alvarez, Fatima Navarro, Rafael Yus Ramos, A. Ramirez De Molina, Santiago Ponce, Pedro Mateos Cruz, Juan Moreno-Rubio, Luis Cabezon-Gutierrez, X. Mielgo Rubio, Gonzalo Colmenarejo, M. Muñoz Fernandez De Leglaría, María Sereno, Amparo Benito
Publikováno v:
Journal of Thoracic Oncology. 14:S917
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4039e22fa002ae807c4501c5c0e0d8a0
https://doi.org/10.1016/j.jtho.2019.08.1990
https://doi.org/10.1016/j.jtho.2019.08.1990